Dijon (France), March 13, 2023 at 6:00 p.m. CET– Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Ticker: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancers, announces today that the publication of the 2022 annual results will take place on April 13, 2023 after market close. The financial report will also be available on that date.
To receive information from ONCODESIGN PRECISION MEDICINE (OPM) in real time, send a request to [email protected]